Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Briggs Morrison currently holds 76,021 shares of Syndax Pharmaceuticals Inc (SNDX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Briggs Morrison has been a net seller of SNDX stock. They have purchased $830.2K and sold $28.8M worth of shares.
Briggs Morrison's most recent insider trade was on Sep 22, 2025, when they purchased 30,000 shares at $7.57 per share.
Briggs Morrison serves as Executive at Syndax Pharmaceuticals Inc (SNDX). They have executed 76 insider transactions totaling $29.6M over their tenure at the company.
Briggs Morrison holds the position of Executive at Syndax Pharmaceuticals Inc, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 7 years and currently hold a stake valued at $0.
Briggs Morrison has shown a selling trading pattern, with $830.2K in total purchases and $28.8M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Briggs Morrison was on Sep 19, 2022, when they sold $2.6M worth of SNDX shares. This transaction involved 114,339 shares at $23.03 per share.
Briggs Morrison currently owns 76,021 shares of Syndax Pharmaceuticals Inc (SNDX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Briggs Morrison's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Briggs Morrison has 76 Form 4 filings on record as an insider at Syndax Pharmaceuticals Inc.
Set alerts for Briggs Morrison and 40,000+ other insiders.